These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 4353352
1. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Kim HW, Arrobio JO, Brandt CD, Wright P, Hodes D, Chanock RM, Parrott RH. Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352 [No Abstract] [Full Text] [Related]
2. Potential of attenuated respiratory syncytial virus vaccine for infants and children. Parrott RH, Kim HW, Brandt CD, Chanock RM. Dev Biol Stand; 1975 Jul; 28():389-99. PubMed ID: 165119 [Abstract] [Full Text] [Related]
3. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Kim HW, Arrobio JO, Pyles G, Brandt CD, Camargo E, Chanock RM, Parrott RH. Pediatrics; 1971 Nov; 48(5):745-55. PubMed ID: 4330595 [No Abstract] [Full Text] [Related]
4. Respiratory syncytial virus in infants and children. Parrott RH, Kim HW, Brandt CD, Chanock RM. Prev Med; 1974 Dec; 3(4):473-80. PubMed ID: 4373702 [No Abstract] [Full Text] [Related]
5. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR. J Infect Dis; 2000 Nov; 182(5):1331-42. PubMed ID: 11010838 [Abstract] [Full Text] [Related]
6. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, Gruber W, Murphy BR, Collins PL. J Infect Dis; 2005 Apr 01; 191(7):1093-104. PubMed ID: 15747245 [Abstract] [Full Text] [Related]
7. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinberg GA, Bromberg K, Loh R, Sly P, McIntyre P, Ziegler JB, Hackell J, Deatly A, Georgiu A, Paschalis M, Wu SL, Tatem JM, Murphy B, Anderson E. J Infect Dis; 2004 Feb 01; 189(3):462-70. PubMed ID: 14745704 [Abstract] [Full Text] [Related]
12. Experimental infection of calves with respiratory syncytial virus. Jacobs JW, Edington N. Res Vet Sci; 1975 May 01; 18(3):299-306. PubMed ID: 167410 [Abstract] [Full Text] [Related]
14. [Investigation on antibodies against respiratory tract virus in children]. Zhao JM. Zhonghua Yi Xue Za Zhi; 1982 Dec 01; 62(12):723-6. PubMed ID: 6301657 [No Abstract] [Full Text] [Related]
15. [Otitis media in infants caused by the respiratory syncytial virus]. Berglund B. Nord Med; 1968 Oct 10; 80(41):1349-52. PubMed ID: 5688185 [No Abstract] [Full Text] [Related]
16. Prevalence of antibodies to respiratory syncytial virus in various populations in Israel. Taya M, Morag A, Abramowitz A, Goldblum N, Zakay-Rones Z. Isr J Med Sci; 1984 Dec 10; 20(12):1146-9. PubMed ID: 6519945 [Abstract] [Full Text] [Related]